Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Panning for anticancer aptamers
09-08-2006
by Randall C. Willis  |  Email the author
SHARING OPTIONS:

GAINESVILLE, Fla.—Although researchers are increasingly using aptamers as high-specificity molecular probes, they generally need purified targets to generate these modified nucleic acids. In the Proceedings of the National Academy of Sciences, however, researchers at the University of Florida describe a way to use key molecular differences between two cell types to effectively "pan" for tissue-specific aptamers without foreknowledge of the molecular targets.
 
The group mixed a library of random single-stranded DNA molecules with cultured leukemia cells, washed away unbound aptamers, and eluted the bound aptamers. They then incubated these oligonucleotides with a control cell line and collected the aptamers that did not bind these cells. The scientists PCR amplified this subset of aptamers and repeated the selection cycle several more times, monitoring cell-aptamer interaction with flow cytometry.
 
After 20 cycles of enrichment, the researchers sequenced the aptamers and found 10 sequences that exhibited binding constants in the nanomolar to picomolar range. Using confocal imaging, the researchers noted that many aptamers recognized different cell subpopulations within a single culture, suggesting that these cells might carry unique molecular signatures. They also noted that the aptamers could distinguish leukemia cells that had been added to healthy human bone marrow aspirates, offering hope of using the aptamers as diagnostic probes in clinical samples.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.